Cargando…
PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is characterized by robust microgliosis and phenotypic changes that accompany disease pathogenesis. Accumulating evidence from genetic studies suggests the importance of phospholipase C γ 2 (PLCG2) in late-onset AD (LOAD) pathophysiology. However, the role of PLC...
Autores principales: | Tsai, Andy P., Dong, Chuanpeng, Lin, Peter Bor-Chian, Messenger, Evan J., Casali, Brad T., Moutinho, Miguel, Liu, Yunlong, Oblak, Adrian L., Lamb, Bruce T., Landreth, Gary E., Bissel, Stephanie J., Nho, Kwangsik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857783/ https://www.ncbi.nlm.nih.gov/pubmed/35180881 http://dx.doi.org/10.1186/s13073-022-01022-0 |
Ejemplares similares
-
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
por: Puntambekar, Shweta S., et al.
Publicado: (2022) -
TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
por: Moutinho, Miguel, et al.
Publicado: (2023) -
Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015) -
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
por: Casali, Brad T., et al.
Publicado: (2018) -
The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model
por: Claes, Christel, et al.
Publicado: (2022)